Skip to content

    Infectious Disease

    Decolonization to Reduce After-Surgery Events of Surgical Site Infection (DECREASE SSI).

    Infectious Diseases, including COVID Trials

    What is the purpose of this study?

    The DECREASE SSI Trial (Decolonization to Reduce After-Surgery Events of Surgical Site Infection) is a two-arm multi-center individual placebo-controlled randomized (2,700 participants randomized 1:1) clinical trial to reduce post-discharge surgical site infection following open colon or small bowel surgery by comparing chlorhexidine bathing plus nasal mupirocin in the 30 days following discharge to soap without antiseptic properties (placebo) and placebo nasal ointment. This trial seeks to enhance the care of the 675,000 patients annually who undergo colon and small bowel surgery by finding simple and efficacious interventions to reduce SSI.

    Eligibility

    • 18 years of age or older
    • Recent open (not solely laparoscopic) surgery involving an abdominal incision within the past 14 days. For cesarean section, recruitment restricted to BMI ≥ 40.
    • Able to communicate regularly by phone
    • Able to bathe, shower or have this task performed by a caregiver

    More about this Clinical Trial

    What is the full name of this Clinical Trial?

    Decolonization to Reduce After-Surgery Events of Surgical Site Infection

    • Principal InvestigatorPhilip Robinson, MD
    • Age GroupAdult, Older Adult
    • PhaseIV
    • IRB NumberSTUDY05586776
    • ClinicalTrials.gov IDNCT05586776

    Stay up-to-date on the latest news from Hoag

    By submitting this request, you agree to receive communications from Hoag and accept our Privacy Policy and Terms of Use.